NIH-funded research R21 grant

Understanding how a protein affects gut health and microbiota interactions

Official title: Novel roles of Fc gamma binding protein in colonic host-microbiota interactions

Funded at University of Alabama at Birmingham · NIH-11166921 · Data updated 2026-11-12

This study is looking at a protein called FCGBP in the mucus of the colon to see how it helps keep our gut healthy, especially for people with conditions like ulcerative colitis and colorectal cancer, and it hopes to find new ways to improve treatments.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startMay 1, 2025
Project endApril 30, 2027
Funding year2025
Award (this year)$222,750
NIH project number1R21AI186312-01A1
Project IDNIH-11166921 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with ulcerative colitis or colorectal cancer, particularly those with known deficiencies in FCGBP.

Less likely to help

Patients without gastrointestinal disorders or those not affected by colorectal diseases may not benefit from this research.

What this research studies

This research investigates the role of Fc gamma binding protein (FCGBP) in the mucus layer of the colon, which is crucial for gut health. By studying mice with varying levels of FCGBP, the researchers aim to uncover how this protein contributes to the structure of the mucus layer and its interaction with gut bacteria. The study also explores the implications of FCGBP deficiency in conditions like ulcerative colitis and colorectal cancer, potentially revealing new insights into disease mechanisms and treatment options.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for colorectal diseases, enhancing patient outcomes.

How similar studies have gone: While the specific role of FCGBP in gut health is not extensively studied, related research on gut microbiota interactions has shown promising results in understanding gastrointestinal diseases.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Maynard, Craig L — University of Alabama at Birmingham
  • Study coordinator: Maynard, Craig L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.